NOVACYT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.819 EUR | +2.89% |
|
-1.33% | +14.87% |
| Apr. 19 | Novacyt: confident ahead of DHSC trial | CF |
| Apr. 19 | Novacyt expects court to dismiss application by UK DHSC | AN |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 23.03 | 13.1 | 8.293 | 618.2 | 259.9 | 76.79 |
| Enterprise Value (EV) 2 | 22.57 | 17.34 | 17.43 | 528.8 | 160 | -9.507 |
| P/E ratio | -2.55 x | -2.69 x | -1 x | 4.51 x | -26.3 x | -2.99 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.54 x | 0.96 x | 0.63 x | 2.23 x | 2.71 x | 3.65 x |
| EV / Revenue | 1.51 x | 1.26 x | 1.33 x | 1.91 x | 1.67 x | -0.45 x |
| EV / EBITDA | -26.5 x | 20.2 x | 32.6 x | 3.01 x | 4.38 x | 0.71 x |
| EV / FCF | -5.39 x | -33.3 x | 7.38 x | 6.38 x | 3.94 x | 2.17 x |
| FCF Yield | -18.6% | -3% | 13.6% | 15.7% | 25.4% | 46% |
| Price to Book | 0.69 x | 0.65 x | 0.53 x | 4.1 x | 1.83 x | 0.67 x |
| Nbr of stocks (in thousands) | 37,572 | 37,561 | 58,039 | 70,620 | 70,616 | 70,582 |
| Reference price 3 | 0.6131 | 0.3489 | 0.1429 | 8.754 | 3.680 | 1.088 |
| Announcement Date | 5/23/18 | 4/29/19 | 6/30/20 | 6/23/21 | 5/1/22 | 4/28/23 |
1GBP in Million2EUR in Million3GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 14.95 | 13.72 | 13.08 | 277.2 | 95.78 | 21.04 |
| EBITDA 1 | -0.853 | 0.858 | 0.534 | 175.6 | 36.54 | -13.41 |
| EBIT 1 | -1.89 | -0.425 | -1.242 | 174.7 | 35.04 | -15.73 |
| Operating Margin | -12.64% | -3.1% | -9.49% | 63.02% | 36.58% | -74.76% |
| Earnings before Tax (EBT) 1 | -5.445 | -2.08 | -3.91 | 165.2 | -9.829 | -20.05 |
| Net income 1 | -5.442 | -4.738 | -6.558 | 132.4 | -9.728 | -25.73 |
| Net margin | -36.39% | -34.53% | -50.13% | 47.77% | -10.16% | -122.29% |
| EPS 2 | -0.2400 | -0.1297 | -0.1434 | 1.940 | -0.1400 | -0.3643 |
| Free Cash Flow 1 | -4.188 | -0.5199 | 2.363 | 82.94 | 40.64 | -4.376 |
| FCF margin | -28.01% | -3.79% | 18.06% | 29.92% | 42.43% | -20.8% |
| FCF Conversion (EBITDA) | - | - | 442.49% | 47.22% | 111.23% | - |
| FCF Conversion (Net income) | - | - | - | 62.63% | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/23/18 | 4/29/19 | 6/30/20 | 6/23/21 | 5/1/22 | 4/28/23 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 4.23 | 9.14 | - | - | - |
| Net Cash position 1 | 0.46 | - | - | 89.4 | 99.9 | 86.3 |
| Leverage (Debt/EBITDA) | - | 4.932 x | 17.11 x | - | - | - |
| Free Cash Flow 1 | -4.19 | -0.52 | 2.36 | 82.9 | 40.6 | -4.38 |
| ROE (net income / shareholders' equity) | -25.5% | -9.38% | -22.5% | 162% | -6.65% | -17.3% |
| ROA (Net income/ Total Assets) | -3.66% | -0.8% | -2.44% | 83.7% | 10.5% | -6.06% |
| Assets 1 | 148.5 | 593.4 | 268.6 | 158.2 | -92.83 | 424.8 |
| Book Value Per Share 2 | 0.8900 | 0.5400 | 0.2700 | 2.130 | 2.010 | 1.630 |
| Cash Flow per Share 2 | 0.1600 | 0.0300 | 0.0300 | 1.300 | 1.440 | 1.230 |
| Capex 1 | 0.91 | 0.38 | 0.22 | 1.01 | 3.77 | 0.16 |
| Capex / Sales | 6.11% | 2.75% | 1.71% | 0.37% | 3.94% | 0.74% |
| Announcement Date | 5/23/18 | 4/29/19 | 6/30/20 | 6/23/21 | 5/1/22 | 4/28/23 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +14.87% | 61.68M | |
| -28.51% | 925M | |
| -20.60% | 128M | |
| -7.82% | 67.46M | |
| +6.64% | 60.58M | |
| +0.60% | 51.45M |
- Stock Market
- Equities
- ALNOV Stock
- Financials Novacyt
